Loading the company…
Loading the company…
Families: Cervical fusion & disc arthroplasty, Lumbar fusion.
All companies · Product and company coverage
In the last ten years FDA made 3 decisions for Nanohive Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2026 (1). The latest was on 2026-02-13.
| Family | Decisions on record |
|---|---|
| Cervical fusion & disc arthroplasty | 2 |
| Lumbar fusion | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-02-13 | 510(k) | K254105 | Hive Standalone Cervical System and Hive C Interbody System |
| 2023-07-12 | 510(k) | K231241 | NanoHive Medical Lumbar Interbody System |
| 2022-12-12 | 510(k) | K223190 | Hive Standalone Cervical System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Nanohive Medical.
In 2025, Nanohive Medical reported engagement with 54 surgeons and other clinicians in the states MedaRep covers, worth $38K in consulting, speaking, meals and travel for its device products, the most in Texas ($8,125 to 8). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Texas ($8,125, 8 engaged), Indiana ($7,256, 3 engaged), Illinois ($3,574, 3 engaged), Oklahoma ($3,251, 4 engaged), Kentucky ($2,875, 1 engaged).